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It is well documented that Indigenous people in Australia, 
Canada, New Zealand, and the United States consistently 
experience substantial inequities in cancer outcomes in 
comparison with their non-Indigenous counterparts, in 
terms of increased incidence,1-3 poorer prospects of treat-
ment,2-4 and higher mortality rates.1-3,5 Current evidence 
suggests that these disparities are attributable to a range of 
factors, including, but not limited to, later stage at diagno-
sis, lower treatment compliance, lower cancer screening 
rates, and social deprivation.3,6
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Abstract
Background: Cancer ‘patients’ are increasingly using traditional indigenous and complementary medicines (T&CM) 
alongside conventional medical treatments to both cure and cope with their cancer diagnoses. To date T&CM use among 
Indigenous cancer patients from Australia, Canada, New Zealand, and the United States has not been systematically 
reviewed. Methods: We systematically searched bibliographic databases to identify original research published between 
January 2000 and October 2017 regarding T&CM use by Indigenous cancer patients in Australia, Canada, New Zealand, and 
the United States. Data from records meeting eligibility criteria were extracted and appraised for quality by 2 independent 
reviewers. Results: Twenty-one journal articles from 18 studies across all 4 countries met our inclusion criteria. T&CM 
use ranged from 19% to 57.7% (differing across countries). T&CM was mostly used concurrently with conventional cancer 
treatments to meet their spiritual, emotional, social, and cultural needs; however, bush, traditional, and herbal medicines 
were used in a minority of cases as an alternative. Conclusions: Our findings highlight the importance of T&CM use to 
Indigenous cancer patients across these 4 countries; we identified multiple perceived spiritual, emotional and cultural 
benefits to its use. The patient’s perception of their health professional’s attitudes toward T&CM in some cases hindered 
or encouraged the patient’s disclosure. Additional research is required to further explore the use and disclosure of 
T&CM among Indigenous cancer patients to help inform and ensure effective, safe, coordinated care for Indigenous cancer 
patients that relies on shared open decision making and communication across patients, communities, and providers.
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Cancer ‘patients’ are increasingly using traditional and 
complementary medicine (T&CM) in addition to conven-
tional medical treatments, such as chemotherapy or radia-
tion therapy, to both cure and cope with their cancer 
diagnosis.7,8 A recent systematic review7 reported a com-
bined prevalence of 40% for current complementary medi-
cine (CM) use in 152 studies, from across 18 countries, 
which included more than 65 000 cancer patients. Horneber 
et al7 also reported that CM use had increased over time 
from approximately 25% in the 1970s to more than 32% in 
the 1990s and to 49% post-2000. Cancer patients’ disclo-
sure of their use of T&CM to health care providers is impor-
tant to assess any potential treatment interactions.9-12
Indigenous people tend to view health from a holistic 
perspective that incorporates physical, cultural and spiritual 
wellbeing and this underpins their care-seeking behav-
iors.6,13 The use of traditional medicine (TM) (eg, singing/
chanting, bush medicine, traditional healers, and external 
remedies) is part of Indigenous culture, continuing tradi-
tions and lore.13 TM is often used to enhance overall well-
being through reconnection to land, spiritual, and ancestral 
roots.6,13 Traditional healers provide spiritual and social 
support that is equally as important as the botanically based 
herbal remedies.13 To date there has been no comprehensive 
review of T&CM among Indigenous cancer patients and 
this manuscript aims to address this gap.
Methods
Eligibility Criteria
TM and CM14 include a broad range of practices, technolo-
gies, products, knowledge systems, and approaches to pre-
venting and/or treating illness and/or promoting well-being, 
which are not historically associated with the conventional 
medical profession or medical curriculum.15 While TM 
refers to health care indigenous to the local culture of users 
(including examples such as herbal medicines and practices 
provided by traditional healers who are usually unregulated 
and operate outside the publicly funded health care system), 
CM refers to health care, both self-administered or practi-
tioner-led, which is often exotic to the culture of users 
(examples include massage, chiropractic, and Western 
herbal medicine).14 As these definitions suggest there may 
well be temporal and geographical fluidity whereby the 
definition of a particular health care practice can be consid-
ered TM or CM depending on the context of use and users.16 
However, despite these possible variations of context both 
TM and CM in the vast majority of cases are largely defined 
by their continuing provision and use beyond the routine 
focus of conventional medical practice.14
Indigenous populations eligible for inclusion in this 
review were from Australia (Aboriginal and Torres Strait 
Islander), Canada (Aboriginal, First Nations, Inuit, or Métis), 
New Zealand (Māori), or the United States (American 
Indian, Native American, Alaskan Native, American 
Samoan, Eskimo, and Native Hawaiian). These countries 
were included because of their shared history of colonization 
and disproportionally worse health in Indigenous popula-
tions.1,3 In this review, we respectfully refer to Indigenous 
people in these 4 countries as “Indigenous” while acknowl-
edging that they comprise many diverse groups with distinct 
languages, beliefs, and cultural practices.
Search Strategy
The search originally aimed to identify peer reviewed liter-
ature reporting new empirical data from qualitative or quan-
titative studies examining T&CM use for 1 of 5 chronic 
diseases (cancer, cardiovascular disease, kidney disease, 
diabetes type 2, or respiratory disease) in adult (18 years 
and older) Indigenous populations from Australia, Canada, 
New Zealand, and the United States. As approximately half 
of all records were unique to cancer at the end of our search, 
this review focuses on cancer only; however, the flowchart 
(Figure 1) and search terms (Table 1) depict the screening 
of studies for all 5 diseases. We required full records of 
original research that were published in a peer-reviewed 
journal from 2000 onward, excluding (a) books or book 
chapters, commentaries, literature reviews, editorials, 
poster abstracts, and dissertations; (b) published languages 
other than English; and (c) efficacy studies (as we are inter-
ested in T&CM use).
We searched AMED, AltHealthWatch, CINAHL, 
EMBASE, PsychINFO, and PubMed for records published 
between January 2000 and October 2017 (the year 2000 
was chosen because of changes in complementary medicine 
and service systems that might limit the applicability of 
studies prior to this date). Keywords included using free-
text terms representing (a) Indigenous populations from 
and residing in Australia, Canada, New Zealand, and the 
United States; (b) common chronic conditions among 
Indigenous populations (ie, cancer, diabetes, heart disease, 
kidney disease, respiratory disease); and (c) terms used pre-
viously for CM,9 which included TM terms (Table 1). In 
addition, we searched the reference lists of articles that had 
previously conducted systematic literature reviews on simi-
lar topics to ours.
Review Process
The systematic review process was guided by the Cochrane 
Collaboration17 and the Centre for Reviews and 
Dissemination18 and the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines19 as outlined in Figure 1.
After removing duplicates, AG and SL independently 
examined titles and abstracts using Covidence systematic 
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review software.20 Articles not meeting eligibility criteria 
were excluded. All retrieved full-text articles were indepen-
dently assessed by AG and SL and the reasons for excluding 
articles were documented and discrepancies were resolved 
by consensus. Extraction of data in qualitative studies was 
conducted via the Joanna Briggs Institute’s method of qual-
itative research synthesis (meta-aggregation) as it avoids 
reinterpreting data and attempts to accurately and reliably 
present the findings of included studies consistent with the 
intent of the original authors.21 AG and SL independently 
piloted this approach21 to achieve consensus on interpreta-
tion and data extraction. AG and SL then proceeded with 
double independent extraction of findings, categories and 
synthesised findings from qualitative studies. Extraction 
discrepancies were documented and discrepancies were 
resolved by consensus.
Quality Appraisal of Studies. The methodological quality of 
each publication was assessed by AG and SL using separate 
tools for quantitative and qualitative studies. Quality 
Figure 1. Study selection and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
Reasons for exclusion: nonindigenous population; indigenous population outside Australia, Canada, New Zealand, and the United States; no traditional 
and complementary medicine (T&CM) use reported; relevant diseases not mentioned in their chronic form (cancer, cardiovascular disease, kidney 
disease, diabetes type 2, or respiratory disease); nonhuman records, for example, animals or plants; not an empirical article reporting original research 
in an IMRaD (Introduction, Methods, Results, and Discussion)–style manuscript; not peer-reviewed; no participants aged 18 years or older; pre-2000; 
non-English; no indigenous breakdown of results.
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assessment for the quantitative studies was conducted using 
the Newcastle-Ottawa Scale (NOS) modified for preva-
lence studies22 and a 6-item critical appraisal tool was used 
for the qualitative studies developed by Kuper et al.23
The NOS scale authors report that the scale has face/con-
tent validity and interrater reliability.24 The modified NOS 
produce a rating out of 5. It assesses the representativeness 
of the sample, the sample size adequacy, nonresponse, mea-
surement of variables and the quality of the descriptive sta-
tistics reporting. Consistent with Cochrane guidance,17 we 
made minor adaptions to the NOS to fit the specifics of our 
review question. Specifically, we altered the first NOS item 
to score studies on variability in remoteness, socioeconomic 
status, gender, and age. In addition, we modified the fourth 
NOS item to represent our topic of interest, T&CM, by 
keeping the validated measurement tool and adding the 
need for a T&CM definition.
The Kuper et al23 quality assessment tool for qualitative 
studies produces a rating out of 6. The 6 questions cover: 
sampling, data collection, data analysis, transferability, eth-
ical issues, and reflexivity and the overall clarity of the 
study. AG and SL piloted the measures, introducing half 
marks for items that had 2-part questions and agreed upon a 
scoring system based on our research question. Furthermore, 
studies with no ethnic breakdown reported, received a 
reduced score, as we were unable to distinguish Indigenous 
from non-Indigenous participants.
Ethics. Ethical approval was not required for this systematic 
literature review.
Results
Of the 794 records retrieved, 195 duplicates were removed 
and 599 records were screened by title and abstract. An 
additional 9 records were identified through checking the 
reference lists. Of the 608 abstracts considered for inclu-
sion, 96 full-text articles were assessed for eligibility, and 
40 records were subsequently considered eligible for inclu-
sion. Of these records, 21 were cancer-related, and as such 
other chronic conditions were excluded (see Figure 1).
Characteristics of the Included Articles
The 21 articles represented 18 individual studies: 3 were 
conducted in Australia,25-29 4 in Canada,30-33 3 in New 
Zealand,34-36 and 8 in the United States.37-45 Most were 
qualitative,26-33,35-42,44,45 (n = 15, 83%), including 2 case 
studies,32,38 and all 3 quantitative studies were cross- 
sectional.25,34,43 All quantitative studies assessed TM as a 
subset of CM, where the qualitative studies differed in 
their focus, with 10 (75%) exclusively examining TM and/
or TM healers; 2 from Australia, 4 from the United States, 
3 from Canada, and 1 from New Zealand.
Most studies included participants from urban/accessible 
areas (n = 6; 33%), or rural areas (n = 8; 44%) and were 
conducted in a range of clinical and community settings. 
Most studies contained solely Indigenous participants (n = 
13; 72%) and females (83.9%). Sample sizes varied exten-
sively, with single clinical case studies, 126 in the largest 
qualitative study and 248 in the largest quantitative study; 
with both samples 100% Indigenous. For those studies that 
reported cancer type (n = 15; 83%), most included partici-
pants with breast cancer (40.5%), followed by digestive 
organ cancers (14.2%) and lung cancer (12.7%).
Of the quantitative studies, only the Australian study 
exclusively sampled an Indigenous population (from 
Queensland, a state of Australia), whereas the others sam-
pled small (n = 26) and moderately sized (n = 129) Indigenous 
subgroups. Seven of 15 qualitative studies investigated TM 





[Title/Abstract search: Indigenous OR Aborigin* OR Torres Strait Islander* OR Māori* OR American Samoa* 
OR First Nation* OR Canadian Indian* OR Native American* OR American Indian* OR Inuit* OR Métis OR 




[Title/Abstract search: cancer* OR neoplasm* OR heart disease* OR cardiovascular disease* OR kidney 
disease* OR renal disease* OR diabetes OR respiratory disease* OR lung disease* CINAHL headings: 
Neoplasms; Diabetes Mellitus; Cardiovascular Diseases; Kidney Diseases; Respiratory Tract Diseases]
CM and TM 
terms
[Title/Abstract search: complementary medicine* OR complementary therap* OR alternative medicine* OR 
alternative therap* OR natural medicine* OR natural therap* OR holistic medicine* OR holistic therap* OR 
Integrative medicine OR traditional medicine* OR bush medicine* OR traditional medicine practice* OR 
ethnomedicine* OR traditional healer* OR traditional practitioner* OR traditional health practice* OR native 
American medicine* OR Native American healing practice* OR spiritual treatment* OR medicine man OR 
medicine men OR native medicine* OR aboriginal healer* CINAHL headings: Alternative Health Personnel; 
Alternative Therapies]
Abbreviations: CINAHL, Cumulative Index to Nursing and Allied Health Literature; CM, complementary medicine; TM, traditional medicine.
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and/or CM use exclusively, with 2 of these 7 being case 
studies. Four qualitative articles intentionally reported on 
TM and/or CM as a subset of a broader focus, often indi-
cated by mention of these practices only in the abstract. 
Seven qualitative studies referred to TM and/or CM in a sec-
tion of the results not devoted to their use.
Using the modified Newcastle-Ottawa scoring guide,24 
the overall scores assigned to each quantitative study out of 
a possible score of 5 was 4.5, 3.5 and 0.5 (see Table 2). 
Using the quality assessment tool of Kuper et al23 for quali-
tative studies, we assigned the 15 studies scores ranging 
from 1 to 5.5 (mean = 3.41) out of 6 possible points (see 
Table 3).
Quantitative Study Findings
Three quantitative studies were conducted, one each in 
Australia,25 New Zealand,34 and the United States.43 Two 
studies focused exclusively on T&CM,34,43 and one reported 
T&CM use within a broader study not focused on T&CM 
use.25 One study included broad terms to assess T&CM use 
(eg, “traditional Indigenous practitioner,” “complementary 
medicine practitioner,” and “relaxation/meditation class”)25 
while the other 2 assessed specific therapies.34,43 Across the 
3 studies, T&CM use ranged from 19% to 57.7%—with 
Maori reporting the highest use and Indigenous Australians 
the lowest (note: we are only reporting on the Indigenous 
populations reported in these studies). Two studies did not 
provide reasons for T&CM use by Indigenous status.34,43 
However, Adams and colleagues25 found all users employed 
T&CM for support with their cancer; however, the specific 
areas of support were not identified. This Australian study 
also identified those patients with an education level of 
high-school or above were more likely to consult a CM 
practitioner than those with education levels less than high 
school (P = .015).25
Qualitative Study Findings
Fifteen qualitative studies were conducted: 2 Australian,26-29 
4 Canadian,30-33 2 New Zealand,35,36 and 7 United States stud-
ies.37-42,44,45 Following meta-aggregation, thematic analysis 
revealed 4 broad themes: (a) perceived efficacy and benefits 
of T&CM, (b) integrating T&CM with conventional treat-
ments, (c) T&CM use as connection to culture, and (d) impact 
of health professionals’ views of T&CM (Table 4).
Perceived Efficacy and Benefits of T&CM. The terms used to 
describe efficacy and benefits of T&CM are often ambigu-
ous, such as believing in it,40 healing,30,33,40,45 and protec-
tion.41 Three studies reported patients’ belief in T&CM as a 
cancer treatment,35,44,45 with 2 studies reporting patients’ 
belief that efficacy depends on the strength of their confi-
dence in T&CM.28,29 The reported benefits of T&CM 
included: helping to cope; stress relief; cleansing and 
strengthening the body; increasing strength, energy, healing 
and recovery; and improving well-being.26-29,33,38,40,41,44,45
. . . it’s a bush or root that you boil it up, but there is something 
in it that is good for insides, just as a cleanser. Makes all your 
body organs healthy and strong, it gets rid of all your internal 
stress28
The exclusive use of TM during palliation was associated 
with “reconnection to land, ancestral and spiritual roots that 
enhanced the person’s overall well-being”; TM was used to 
Table 2. Characteristics of Included Quantitative Studies.
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26 (13%) NIB Self-administered 
postal 
questionnaire
15 of 26 (57.7%) 
used T&CM
NIB 0.5
USA—Alaskan Native, Native American, and Native Hawaiian
Maskarinec 
et al (2000)43
State of Hawaii Quantitative 
cross-
sectional
129 (12.9%) NIB Self-administered 
postal 
questionnaire
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Table 4. Findings Summary of Main Themes Identified via Meta-Aggregation.
Themes Key Findings Example Quotes
Perceived efficacy 
and benefits of 
T&CM
Ambiguous terms to describe T&CM 
efficacy
“13 (93%) of the CAM users expressed belief in CAM and/or 
valued CAM.” (Arthur et al)37(p235)
“I firmly believe that 75% of why I’m going to make it is going to be 
because of Indian medicine. Somehow or another it’s working. I don’t 
have the kind of faith in your medicine that I have in Indian medicine. 
I still give some credit to Western medicine and so, I have to give you 
guys [Western doctors] 25%.” (Struthers and Eschiti)44(p18)
“All of the women interviewed shared the importance of 
balancing mind, body, and spirit in their efforts toward taking 
care of self and achieving a state of health and well-being.” 
(Canales)39(p422)
“A connection to spirituality and holistic health worldview: 
Healing is mental, emotional and spiritual as well. For some 
participants the application of bush medicine was not only 
seen as relieving stress but was also seen as an enabler in 
maintaining their connections and beliefs on culture, ancestors 
and spirituality. The practice of bush medicines confirmed 
and supported participant’s cultural beliefs and attitudes that 
conformed to Aboriginal understandings and epistemologies of 
health and wellbeing as holistic.’ (Shahid et al)28(p4)
“Linda developed pneumonia while undergoing chemotherapy 
and was hospitalized for 3 weeks. She lost 20 pounds. Family 
members contacted the medicine man, and Linda was given 
another herb to help stimulate her appetite.” (Bucher)38(p113)
“He asked about alternative medicines. One relative who was 
in America had told him about a plant that could be used 
that was better than chemo and radiation and so he asked 
for information that could prove that, but he got no further 
information. Proof was particularly important as he had 
another relation who had died from cancer many years before 
after rejecting radiation and using an alternative approach in 
Mexico, so he concluded that “I’m afraid I’ve got no trust in 
them.” (Dew et al)35(p146)
Belief in T&CM
Holistic benefits of T&CM
T&CM used to reduce side-effects 
and assist in palliation
Lack of evidence about efficacy or 





Integrated T&CM with conventional 
treatment
“CM users did not express a current or continued dissatisfaction 
with their conventional cancer treatment. Instead, they 
expressed satisfaction with the combination of conventional 
treatment and CAM use, because they did not want to 
limit themselves to conventional medicine alone.” (Arthur 
et al)37(p236)
You have to use both [traditional and conventional]. But in terms 
of taking care of myself, obviously I’ve swung right back over 
toward [traditional] . . . but obviously a modern lab makes my Dim 
[dinomethyl], makes my Q-Co-10 [herbal remedy]. I’ll do whatever, 
but I grow my own burdock [for tea]. (Canales)39(p418)
“Adverse reaction from biomedicine: Radiation and chemo nearly 
killed me. I know a couple of people who chose the bush medicine 
once they read up about chemotherapy and the two per cent of 
people that chemo cured, they took their chances with the bush 
medicine, and they are still going. It’s either the quality of life or 
being sick from the chemo, that’s what they weighed up. (Shahid 
et al)28(p6)
“There are some Aboriginal people who use traditional medicine 
as an alternative to Western medicine. Both cancer patients 
and the family members felt some people get scared about the 
intensive procedures of common cancer treatments and their 
side-effects, influencing them to choose other options instead.” 
(Shahid et al)28(p6)
T&CM used for curative properties, 
coping or preventing recurrence
Rejection of conventional treatment 
and opt for TM only
Seeking TM after failure of 
conventional treatment
 (continued)
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Themes Key Findings Example Quotes
T&CM use as 
connection to 
culture
Indigenous holistic concept of health 
ways of healing
“They participated and took initiative in their treatment because 
of the belief that wellbeing is holistic. A holistic view of well-
being meant that the conventional treatment plan was only part 
of their solution.” (Arthur et al)37(p236)
“Making connections with community and family provided 
important coping for a population that is economically, 
socially, and physically isolated . . . There’s traditional medicine, 
I believe in it, too. Because all your relatives come together. I 
really like the environment when everybody comes as one, and it 
makes you feel real good. It makes you feel just uplifted. While 
participants referenced different spiritual foundations to 
their prayer, the common theme in these interviews was the 
power of spirituality to bring people together.” (Haozous 
et al)40(p408)
“Generally the women in this study had a good knowledge 
of environmental and biological causes of cancer but they 
also believed in the spiritual forces of ‘bad spirits’ aroused 
as ‘payback’ to inflict the victim with a serious disease like 
cancer. Such beliefs added to the difficulty of the patients 
who may be reluctant to talk about their disease for fear 
of bringing shame to their family. But an important aspect 
of this view that cancer was a result of ‘payback’ were the 
beliefs that traditional medicine and Aboriginal healers 
were essential to the health care of the sick person, either 
with or maybe instead of, conventional medical treatment.” 
(Prior)27(p9)
“She respects the fact that her family has decided to follow 
Christian ways; however, she wants her passing to be marked in 
traditional ways. This means that certain ceremonies must take 
place for her to have a peaceful transition to the spirit world.” 
(Clarke and Holtslander)32(p34)
“Shelley, who identified as a Métis woman and had recently 
re-connected to her family’s cultural values and traditional 
practices, took a photo of her family sweat lodge explaining 
that it was a salient part of her recovery from breast cancer. 
For her, it was a source of connection to traditional values and 
family and a source of strength. The sweat lodge was also seen 
as a safe place for healing—a place free of racism.” (Poudrier 
and Mac-Lean)30(p311)
The sweat lodge ceremony is a big part of my life and that’s where I 
did most of my healing . . . Anything and everything in there is safe. 
Everything in there is equal because when that door is closed its 
black. So nobody, there’s no color. There’s no racism in there. There 
is nothing in there. It’s really like a positive experience. (Poudrier 
and Mac-Lean)30(p312)
T&CM use to counter spiritual 
forces/payback
Family and community encouraged 
use
Fits with cultural values and beliefs
Opposed to conventional medicine
Connection to family (bridges 
isolation gap)
Didn’t want to be far away from 
home/family
Impact of health 
professionals’ 
views of T&CM
Lack of knowledge of T&CM by 
health providers
“Service providers need to acknowledge and understand the 
existence of Aboriginal knowledge (epistemology) and accept 
that traditional healing can be an important addition to an 
Aboriginal person’s healing complementing Western medical 
treatment regimes.” (Shahid et al)28(p1)
“She didn’t trust the Western medical system because in her view 
it belittled Maori medicine and people were still dying under 
western medical treatment.” (Dew et al)35(p146)
Health professionals dismissive of 
TM
Health professionals’ lack of respect 
for TM hinders communication
Patients unlikely to disclosure T&CM 
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Themes Key Findings Example Quotes
“The women in this study recalled their apprehension about 
declaring preferences for traditional approaches to treatment 
because they feared being ridiculed by the hospital staff. The 
culturally appropriate mantra of cancer control misses the point 
unless there is a deeper engagement of Aboriginal people in 
their own health care, so that real choices are possible and the 
significance of culture is understood and respected.” (Prior)26(p285)
“Though most respondents who discussed the use of traditional 
medicine with their care providers were met with support, 
some participants were either reluctant to share this 
information with care providers or felt disregarded, such as this 
survivor who reported: I tried to (discuss traditional medicine with 
providers). It was kind of one of those things where they didn’t want 
to hear it. They didn’t want to discuss it . . . They didn’t take the 
things I said seriously. They treated me like I was a complete idiot, 
and that was really, really difficult.” (Hohl et al)41(p2441)
“The data suggest that when conventional providers respect 
native beliefs and traditions, are knowledgeable about natural 
practices, and recognize the influence of traditional world views 
on Native women’s health and health care decisions, Native 
women are more open to, and trusting of, the conventional 
health care system.” (Canales)39(p433)
Abbreviation: T&CM, traditional and complementary medicine.
reduce side effects of chemotherapy, including weight and 
appetite loss.38 For many patients, TM was described as a 
highly valued Indigenous way of healing that was attributed 
to health improvements.28,30,40,44 TM was said to work best 
when patients are diagnosed early, believe in the value of 
TM, and have a strong desire to fight cancer.44 Some partici-
pants had safety concerns about TM—citing the paucity of 
evidence relating to efficacy, the lack of prescription infor-
mation and previous experiences of allergic reactions or 
interactions with other medications.28,35
Integrating T&CM With Conventional Treatments. Most partic-
ipants used T&CM alongside conventional cancer treat-
ments,28,35-39,42,44 while a minority replaced conventional 
treatments with TM.28 Some participants used TM for cur-
ing their cancer,28,30,44 some for healing and coping, and oth-
ers to prevent recurrence,39 while some used it only as a last 
resort.28,35 One participant speaks of fully integrating the 2:
In between having my surgery, convalescing, and coming back 
home, they had done ceremonies to heal me.44
One participant explains why some people rely solely on 
TM:
I know a couple of people who chose the bush medicine once 
they read up about chemotherapy . . . they took their chances 
with the bush medicine, and they are still going. It’s either the 
quality of life or being sick from the chemo, that’s what they 
weighed up.28
Integrating TM and conventional medicine was common 
for some participants and this flowed naturally into their 
cancer treatment.28,39,44 Some participants used T&CM on 
recommendation from community members or after seeing 
others benefit.28 Some decided against using conventional 
treatments in order to stay with family and community or 
due to their care responsibilities.28
T&CM Use as Connection to Culture. Evidence that Indige-
nous cancer patients employ alternative health paradigms 
when using TM is consistent with Indigenous holistic con-
ceptions of health.28,36,37,39,42,44 TM was associated with 
spirituality in all Indigenous cultures and the practice of TM 
with holistic healing.28,36,37,39,42,44 Prior and colleagues 
argued that TM usage is an active choice that fits with 
Indigenous cultural values26 and offers Indigenous patients 
a safe place for healing that is free of racism.30 Some par-
ticipants expressed distrust and opposition to conventional 
treatment:
I said, “No, I’m not going that way. I’m going to stay with the 
rongoa”. The Māori herbal way.35
The role of TM in maintaining family and community 
connections was an important coping mechanism for 
Table 4. (continued)
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participants; particularly given the common shame and 
stigma associated with a cancer diagnosis.28,40,42 The com-
munal nature of many TM therapies encourage connection 
between patients, family, and community.26,28,30,35,38,40,42,44 
Many participants desired to use TM,28,35,42,44 however, 
reported barriers facing urban participants included dis-
tance from traditional healers who are predominantly in 
remote and rural areas,28,35,42,44 uncertainty about accessing 
TM,28,35 lack of connection to Indigenous culture, and a 
preference for conventional medicines.
Indigenous Australians spoke of cancer being caused by 
spiritual forces associated with “payback”28 and TM was 
seen as essential in countering such forces.28 For some, TM 
ensured a peaceful passage into the afterlife.32,38 Shahid and 
colleagues28 stated that many Aboriginal Australians were 
brought up on missions with strong Christian beliefs that 
associated TM with paganism:
We didn’t use traditional medicine or anything like that. 
Because we are not traditional Aboriginal, and our family was 
Christian based, and so . . . We put our trust on God.28
Impact of Health Professionals’ Views of T&CM. When con-
ventional healthcare providers respected and had knowl-
edge of TM, Indigenous patients’ satisfaction reportedly 
increased,28,39,41 and they had confidence and trust in con-
ventional medical services.28,39 Participants who used CM 
and/or TM were reportedly more actively engaged in their 
treatment plans.26,37
Most studies found that health professionals had little 
understanding of traditional beliefs and values of 
Indigenous cultures,26-30,36,39,41,44 which negatively affected 
communication and patients satisfaction.29,36 Some authors 
argue that culture and spirituality is central to healing and 
argue that TM could improve cancer outcomes.28,44 Health 
professionals need to counter “white man’s authority”27 in 
health care and better “negotiate a balance between the 
different cultural paradigms.”26 TM use had variable sup-
port from health professionals and there was a perceived 
lack of respect for TM, which arguably hinders patient-
provider communication, reducing the likelihood of 
patients disclosing their T&CM use. Some participants 
felt belittled in their choice to use TM,35,39,41 as one par-
ticipant describes:
I tried to (discuss traditional medicine with providers). They 
didn’t take the things I said seriously.41
While a minority of health professionals were openly 
accepting of TM, some participants reported some of their 
health care providers were personally interested in TM, but 
reluctant to openly discuss it, as it is generally disapproved 
of in conventional healthcare settings.41
Discussion
This systematic review reports on the use of T&CM by 
Indigenous cancer patients in Australia, Canada, New 
Zealand, and the United States. We identified 21 journal 
articles25-45 from 18 studies that inform understandings of 
usage of T&CM across all 4 countries.
Most of the articles in this review were qualitative, with 7 
investigating T&CM use exclusively.28,32,33,37,38,44,45 Two32,38 
of these were case studies; 4 articles reported TM and/or CM 
use as a component of a broader study (eg, a study on quality 
of life)29,35,39,40; and the remainder made some reference to 
T&CM use within their results.26,27,30,31,36,41,42
The number of quantitative studies was small. All 
explicitly focused on TM and/or CM use, but only 1 
Australian study exclusively sampled an Indigenous popu-
lation (Queensland, a state of Australia),25 whereas the oth-
ers sampled34,43 Indigenous people as a subgroup. The 
estimated extent of T&CM use in the quantitative articles 
varied from 19% in Indigenous Australians,25 58% in 
Maori in NZ34 and 29.8% in Native Hawaiians.43 The 
Australian study may have produced the lowest estimate 
because of the limitations of having only 5 options for 
reporting the type of T&CM used in a structured question-
naire, which would miss some types of T&CM. In contrast, 
the US study43 and the NZ study34 collected much more 
detailed T&CM information asking 21 and 19 questions, 
respectively. The estimate of T&CM in Native Hawaiians 
may be lower relative to the New Zealand study as the 
study collected data pre-2000, which yields lower esti-
mates relative to studies conducted in the year 2000 or 
after.7 It is known that restricting CM use to certain catego-
ries or treatments reduces estimates,7 and makes compari-
sons difficult. Therefore, the use of consistent definitions 
and measurements are recommended using standardized 
and validated tools such as the International Complementary 
and Alternative Medicine Questionnaire (I-CAM-Q).46 
While standardization is critical improving overall under-
standing of the types and prevalence of T&CM use among 
Indigenous people, the validity of such tools to measure the 
diversity of TM is often questioned.47 It has been previ-
ously reported that when evaluating CM use in ethnically 
diverse populations, ethnic-specific modalities should be 
recognized7; this should also include TM.
High heterogeneity was observed in the quantitative 
studies, which is consistent with the 2012 systematic review 
and meta-analysis of CM use in non-Indigenous cancer 
patients that reported estimates ranging between nine and 
88%.7 These disparate estimates speak to the importance of 
consistency in survey methods. In light of this, we advocate 
following the recommendations of Horneber and col-
leagues’ review7 to improve the relevance, reliability, valid-
ity, and reporting of future surveys assessing CM use in 
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cancer patients. These recommendations relate to improve-
ments in the conduct and reporting of future surveys of CM 
use in cancer patients, and specify 10 quality criteria, with 
recommendations on how these criteria should be fulfilled 
and reported.
It is evident from the current thematic analysis that 
Indigenous populations perceive T&CM as more than just a 
treatment for physical symptoms, and a cure for cancer. 
Indigenous people who use T&CM also do so as intrinsic to 
their wider belief system as a means of maintaining connec-
tions with family and community.13 Similarly, Iwasaki 
et al48 found that Indigenous people in Canada used T&CM 
as a means to impart spirituality, which they see as sacred 
and fundamental to their lives; in particular to their ability 
to cope and heal from their diabetes.48 It is important that 
health professionals recognize this and be respectful when 
engaging in conversations about T&CM use. This also 
speaks to the importance of creating safe spaces in health 
services to make patients feel comfortable discussing 
T&CM and disclosing its use. The importance of open and 
effective patient-clinician communication is paramount to 
assessing the potential risks and benefits associated with the 
use of T&CM in the cancer setting.49,50 Indeed, effective, 
safe, and coordinated care for Indigenous cancer patients 
relies on shared open decision making and communication 
across patients, communities, and health care providers. 
Therefore, it is important for health professionals and poli-
cymakers to ensure that the care afforded to Indigenous 
cancer patients is culturally relevant, safe, effective, and 
optimal wherever and as much as possible.
Future research in this area would benefit from address-
ing some of the questions not addressed in the current 
review. In particular, studies looking at predictors of T&CM 
use in Indigenous populations. For instance, does the use of 
T&CM have an impact on the time taken to seek Western 
medical treatments for cancer? What are Indigenous peo-
ple’s perceptions and beliefs regarding the ability for 
T&CM to prevent or cure cancer; does this impact or prompt 
T&CM use? Its questions like these that will help to form a 
clearer understanding about the potential motivations and 
predictors of T&CM use in Indigenous populations. 
Furthermore, there is a clear lack of research focused on 
determining the actual percentages of Indigenous people 
from Australia, Canada, New Zealand, and the United 
States that are using T&CM either alongside or instead of 
conventional cancer treatments. Without accurate quantita-
tive data in this area, we are not able to show the signifi-
cance of this phenomenon.
Conclusion
The current review identified wide variations in the esti-
mates of T&CM use among Indigenous cancer patients, per-
haps due to methodological variety across studies. This 
review highlights the importance of understanding the cul-
tural beliefs of Indigenous people with cancer about the 
effectiveness and safety of T&CM, and in providing clinical 
information known about the T&CM treatments to enable 
Indigenous people to make informed choices. These find-
ings are also a reminder of the importance of reflexivity 
when working with Indigenous populations, to recognise 
and set aside health professionals’ own backgrounds, posi-
tions, perspectives, paradigms, experiences, and biases, 
which have an impact on attitudes to T&CM use and patient-
practitioner relations. The review results highlight a critical 
need for further research investigating T&CM use, decision-
making and information seeking among Indigenous cancer 
patients, to help inform health practitioners and policy mak-
ers on how to create culturally relevant, safe, effective, and 
optimal care for Indigenous cancer patients wherever and as 
much as possible.
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